Abstract:Resveratrol is a nonflavonoid polyphenolic compound which has a broad range of desirable biological actions which include antioxidant, anti-inflammatory, antidiabetic, cardioprotective, and antitumor activities. However, there is concern that the bioavailability of resveratrol may limit some of its clinical utility. So, the aim of this study was to enhance the dissolution rate and oral hypoglycemic and hypolipidemic effect of resveratrol. This was achieved using self-emulsifying drug delivery system. The solubility of resveratrol was determined in various oils, surfactants, and cosurfactants. Phase diagram was plotted to identify the efficient self-emulsification regions using olive oil, Tween 80, and propylene glycol. The prepared self-emulsifying drug delivery system formulations were tested for thermodynamic stability, emulsification efficiency, droplet size, zeta potential, and in vitro drug release. Self-emulsification time averaged 17-99 seconds without precipitation and the mean droplet sizes ranged from 285 to 823 nm with overall zeta potential of -2.24 to -15.4 mv. All formulations improved drug dissolution in relation to unprocessed drug with a trend of decreased dissolution parameters with increasing oil content. The optimized formula, F19, with dissolution efficiency of 94% compared to only 42% of pure drug was used to study the in vivo hypoglycemic and hypolipidemic effects of resveratrol in diabetic-induced albino rats and comparing these effects with that of pure resveratrol in different doses. Treatment with the optimized formula, F19, at 10 mg/kg had significant hypoglycemic and hypolipidemic effects in diabetic-induced albino rats which were nearly similar to the high dose (20 mg/kg) of unprocessed resveratrol. From the study, it was concluded that formulation F19 has good emulsification property with uniform globule size, satisfactory in vitro drug release profile, and significant in vivo hypoglycemic effects which identify future opportunities for resveratrol delivery.

Preparation and Characterisation of A Soy Lecithin-Based Self-Microemulsifying Drug Delivery System of Resveratrol

Resveratrol Loaded Self-Microemulsifying Drug Delivery System (SMEDDS): Development and Optimization

Optimization of a Self-Microemulsifying Drug Delivery System for Oral Administration of the Lipophilic Drug, Resveratrol: Enhanced Intestinal Permeability in Rat

Development Of Phospholipid Complex Loaded Self-Microemulsifying Drug Delivery System To Improve The Oral Bioavailability Of Resveratrol

Preparation and Stability Evaluation of Self- Microemulsifying Drug Delivery System for Coenzyme Q10

A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism

Self-microemulsifying Drug Delivery System for Improved Oral Delivery of Limonene: Preparation, Characterization, in Vitro and in Vivo Evaluation

Design and Evaluation of A Self-Microemulsifying Drug Delivery System for Apigenin

Preparation of a supersaturatable self-microemulsion as drug delivery system for ellagic acid and evaluation of its antioxidant activities

Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol

Preparation and Quality Evaluation of Ginkgolide B-loaded Self Microemulsifying Drug Delivery System

Enhanced Oral Bioavailability of Daidzein by Self-Microemulsifying Drug Delivery System

Self-microemulsifying Drug Delivery System for Improved Oral Bioavailability of Oleanolic Acid: Design and Evaluation.

Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.

Lecithin-Polysaccharide Self-Assembled Microspheres for Resveratrol Delivery

Development of Carboxymethyl Chitosan-Coated Zein/soy Lecithin Nanoparticles for the Delivery of Resveratrol

Preparation and Characterization of Pelletized Solid Dispersion of Resveratrol with Mesoporous Silica Microparticles to Improve Dissolution by Fluid-Bed Coating Techniques

Development of self-microemulsifying drug delivery system for honokiol

Self-Micro-Emulsifying Controlled Release of Eugenol Pellets: Preparation, in Vitro/in Vivo Investigation in Beagle Dogs.

Preparation and evaluation of self-microemulsifying drug delivery systems containing atorvastatin

Preparation and evaluation of self-microemulsifying drug delivery system of baicalein